PGxAI
EN AR
Contact Request Access
scope image
Overview

Collaborations that Propel Innovation

From our early days, PGxAI recognized the importance of forging strategic alliances. Today, our partnerships and global market footprint underscore our commitment to transforming healthcare through secure, cutting-edge pharmacogenomics.
Market Reach
Why Work at PGxAI?
integration icon
Presence in Diverse Regions
PGxAI's solutions are deployed across North America, Europe, and select Asia-Pacific markets, tailoring language and compliance to local requirements.
The Road Ahead
Join Our Mission to Redefine Healthcare
By prioritizing data integrity, clinical accuracy, and a user-centric design, PGxAI continues to set new benchmarks for secure, AI-driven pharmacogenomics, empowering the healthcare ecosystem to make smarter, safer treatment decisions.
Rapid Revenue Growth
Rapid Revenue Growth
Early traction in oncology, cardiology, and psychiatry domains drives year-over-year adoption by health systems and labs.
Robust Client Feedback
Robust Client Feedback
Case studies indicate measurable drops in adverse drug events and significant improvements in trial success rates, reinforcing PGxAI's market momentum.
Continual Innovation
Continual Innovation
Regular releases of expanded gene-drug coverage, enhanced AI models, and interoperable APIs keep PGxAI at the forefront of precision medicine.
Trusted by Leaders
Our Milestones & Partners
We collaborate with the world's leading healthcare and tech organizations to bring advanced pharmacogenomic solutions to every corner of the globe
company logo
InterSystems
Cambridge, MA, USA
Close

Strategic integration and interoperability initiatives in precision medicine.

company logo
Google Cloud
Mountain View, CA, USA
Close

Cloud AI enablement for scalable pharmacogenomics workloads.

company logo
Microsoft
Redmond, WA, USA
Close

Joint modernization and data platform initiatives for healthcare delivery systems.

company logo
NVIDIA
Santa Clara, CA, USA
Close

GPU acceleration for clinical AI and model inference pipelines.

company logo
Sequencing.com
San Diego, CA, USA
Close

Sequencing and assay ecosystem collaborations to expand clinical coverage.

company logo
Anthropic
San Francisco, CA, USA
Close

Applied AI collaboration for safe, governed clinical intelligence workflows.

company logo
FDA iSTAND
Silver Spring, MD, USA
Close

FDA CDER ISTAND Pilot Program supporting innovative drug development tools and regulatory science.

company logo
The University of British Columbia
Vancouver, BC, Canada
Close

Academic partnership with the University of British Columbia to accelerate pharmacogenomics research, clinical translation, and precision-medicine education.

1M+
in Grants & Partnerships
12
Therapeutic Areas
50K+
Tests Conducted, Validated & Reimbursed
900+
Substances
150+
Genes Covered
Early Validation
As we continue to broaden our market presence, PGxAI remains dedicated to forming impactful partnerships that amplify the potential of AI-driven pharmacogenomics.
By uniting leading technology providers, healthcare institutions, and research organizations, we're shaping an era of truly personalized care, one that prioritizes patient safety, cost-effectiveness, and seamless global collaboration.
Get in Touch
Ready to Shape the Future of Precision Medicine?